Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Mechanism of Response to PD-1 Blockade in NSCLC: A Pilot Study

NCT03877250 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03877250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03877250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Mechanism of Response to PD-1 Blockade in NSCLC: A Pilot Study
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Withdrawn
Start date
March 8, 2019
Completion date
August 26, 2020
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer